Document Detail

Prevalence of antiphospholipid antibodies in Syrian patients with thrombosis.
MedLine Citation:
PMID:  19801789     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: Antiphospholipid antibodies (aPL) are a heterogeneous family of antibodies associated with thrombosis and other complications. OBJECTIVE: To study the prevalence of aPL in patients with thrombosis at Aleppo University Hospitals, Syria. METHODS: One hundred and fifty-seven patients with venous and arterial thrombosis and 63 healthy controls were studied. Anticardiolipin antibodies (aCL) and Lupus anticoagulant (LA) were determined. RESULTS: Thirty-four out of 157 (21.7%) patients with thrombosis had some type of aPL. aPL was also found in four healthy subjects (4/63=6.3%). Eighteen patients (11.5%) were positive for LA, 20 (12.7%) for aCL antibodies and 4 (2.6%) were positive for more than one aPL. Patients without risk factors for thrombosis and having positive aPL were 23/34 (67.7%). Fourteen out of 78 (17.9%) patients with arterial thrombosis, and 20/79 (25.3%) with venous thrombosis were positive for at least one aPL. CONCLUSION: Our study showed a significant prevalence of aPL in patients with thrombosis. It seems that aPL is a risk factor for venous and arterial thrombosis, especially in patients with no conventional risk factors.
Ali Deeb; Said Hamdoun; Khaled Dababo
Related Documents :
7645539 - Vascular access thrombosis in new hemodialysis patients.
15053809 - Heterozygous methylene tetrahydrofolate reductase mutation with mild hyperhomocysteinem...
15535889 - The role of d-dimer as first marker of thrombophilia in women affected by sterility: im...
19614999 - Dermal mucinosis as a sign of venous insufficiency.
21083469 - Pharmacology of argatroban.
6083619 - Early phlebographic results after iliofemoral venous thrombectomy.
8646959 - Microchip implants on the anterior sacral roots in patients with spinal trauma: does it...
22541979 - Bone mineral density in adult patients treated with various antiepileptic drugs.
3103439 - Defective release of tissue plasminogen activator in systemic and cutaneous vasculitis.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Iranian journal of immunology : IJI     Volume:  6     ISSN:  1735-1383     ISO Abbreviation:  Iran J Immunol     Publication Date:  2009 Sep 
Date Detail:
Created Date:  2009-10-05     Completed Date:  2010-01-11     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101282932     Medline TA:  Iran J Immunol     Country:  Iran    
Other Details:
Languages:  eng     Pagination:  154-9     Citation Subset:  IM    
Departments of Internal Medicine, Aleppo University, Syria.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Antibodies, Anticardiolipin / blood*
Antibodies, Antiphospholipid / blood*
Lupus Coagulation Inhibitor / blood*
Middle Aged
Seroepidemiologic Studies
Syria / epidemiology
Thrombosis / blood*,  diagnosis,  epidemiology
Young Adult
Reg. No./Substance:
0/Antibodies, Anticardiolipin; 0/Antibodies, Antiphospholipid; 0/Lupus Coagulation Inhibitor

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Serum Levels of TNF-alpha, TNF-alphaRI, TNF-alphaRII and IL-12 in Treated Rheumatoid Arthritis Patie...
Next Document:  Presidential Address: Quarantining Women: Venereal Disease Rapid Treatment Centers in World War II A...